The Role
The Senior Director, Payer Accounts is responsible for managing a team to maximize product access, negotiating contracts with payers, and collaborating with internal teams for market access strategies.
Summary Generated by Built In
Who We Are
Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Our Team
https://cogent.culturehq.com
The Senior Director, Payer Accounts is a field-based positionresponsible for managing a team of Account Directors focused on gaining and maintaining broad coverage and access for Cogent’s products. This individual will be responsible for building and maintaining relationships with key stakeholders including regional payers, pharmacy benefit managers (PBMs), MACs and state Medicaid agencies. They will collaborate extensively with internal departments and functions to incorporate customer insights into pricing, contracting and market access strategies including Marketing, Sales, and Sales Operations, Patient Services, and Legal.
Responsibilities
- Lead payer team to develop and implement strategies to maximize product access.
- Establish and maintain relationships with key decision makers, including medical and pharmacy directors.
- Negotiate and execute contracts with assigned targeted accounts, help provide access for clinical and/or economic discussions.
- Ability to articulate the value proposition of Cogent’s products to appropriate customers.
- Collaborate and align on pricing & contracting strategies, HEOR evidence generation plans and payer marketing initiatives.
- Work with multiple stakeholders across internal divisions (Sales, Contract & Pricing, Medical, Trade, Legal/Compliance and Marketing) and serve as the main point of contact for account and decision making.
- Formulate, implement, and regularly assess business plan with internal team members to achieve business objectives and utilize all available resources to maximize product & patient access.
- Adhere to relevant regulatory and compliance guidelines and Company policies.
- Attend and participate in meetings and/or conferences as requested by management.
Essential Requirements
- Bachelor’s degree required, MBA or other advanced degree preferred.
- 10-12+ years of pharmaceutical industry experience with at least 8 in market access account management and/or leadership.
- Demonstrated success in engaging with US Payers, including PBM’s, state Medicaid agencies etc.
- Strong abilities in communication and presentation skills.
- Skilled in strategic thinking, leadership negotiation and relationship management.
- Ability to travel up to 50%.
Desired Requirements
- Success in gaining preferred formulary positioning for key products within targeted accounts.
- Demonstrated leadership, project management and team development ability along with ability to work collaboratively with peers and management.
- Launching of new product/start-up experience.
Our Locations
Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.
Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.
Our Offer To You
To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Am I A Good Fit?
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.
Success! Refresh the page to see how your skills align with this role.
The Company
What We Do
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging validated biology to advance precision therapies designed to address the true underlying drivers of disease and provide real hope for patients. Cogent’s lead therapeutic candidate, bezuclastinib (CGT9486), is a precision kinase inhibitor designed to selectively and potently inhibit the KIT D816V mutation. This mutation is responsible for driving a rare and serious condition called Systemic Mastocytosis which can severely impact many different tissues and organs in the body. We are also studying CGT9486 to treat advanced gastrointestinal stromal tumors (GIST), which have a strong dependence on oncogenic KIT signaling.
.png)
